Talimogene Laherparepvec in Combination With Pembrolizumab Leads to a Complete Response in a Patient With Refractory Merkel Cell Carcinoma

JAAD Case Reports - United States
doi 10.1016/j.jdcr.2018.10.003
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV